Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Topiramate NDC 68462-218 by Glenmark Pharmaceuticals Inc., Usa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure1 - figure1
This is a table showing the cumulative rates for the time to the first seizure for two groups: one group taking Topiramate 50 mg/day (N=234) and the other group taking Topiramate 400 mg/day (N=236). The chart displays time in days on the x-axis and the cumulative rates on the y-axis. This data can be used to compare the effectiveness of the two different doses of Topiramate in preventing seizures over time.*
figure2 - figure2
This text provides data on the change from baseline to the double-blind phase in average monthly migraine period rate for different doses of placebo and topiramate. The study includes three different groups with varying doses of topiramate (100 mg/day and 200 mg/day) and a placebo group. The numbers of participants in each group are also mentioned. The results indicate statistically significant differences between the groups, as denoted by the p-values provided.*
structure - image 01
label15mg - label15mg
label25mg - label25mg
logo - logo
logo2 - logo2
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
